Lipid Management Strategies for the Prevention of Adverse Cardiovascular Events

Publisher： Karger

E-ISSN： 1424-0556|2|4|159-161

ISSN： 1422-9528

Source： Heart Drug, Vol.2, Iss.4, 2002-11, pp. : 159-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Lipid Management for the Prevention of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse drug reactions: current issues and strategies for prevention and management

By Singer Donald RJ Khong Teck K

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1289-1300

Informa Healthcare

Access to resources Recommend Favorite

Verapamil for preventing adverse cardiovascular events

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Ephedra: risk of adverse cardiovascular events

Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

By Nelson M.R. Reid C.M.

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 897-903

Adis International

Access to resources Recommend Favorite